Stockscreener 앱 받기
40.65
0.49%
0.20
시간 외 거래:
40.65
전일 마감가:
$40.45
열려 있는:
$40.24
하루 거래량:
2.09M
Relative Volume:
0.92
시가총액:
$8.38B
수익:
$2.09B
순이익/손실:
$424.88M
주가수익비율:
19.89
EPS:
2.0439
순현금흐름:
$447.20M
1주 성능:
-1.14%
1개월 성능:
-15.87%
6개월 성능:
-11.52%
1년 성능:
+2.52%
1일 변동 폭
$40.16
$40.90
1주일 범위
$40.16
$42.07
52주 변동 폭
$38.13
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
40.65 | 8.34B | 2.09B | 424.88M | 447.20M | 2.0439 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-22 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention - Business Wire
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Headwinds Amid Genomics Slowdown and Strategic Shifts - AD HOC NEWS
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
Release according to Article 40, Section 1 of the WpHG - TradingView
Moors & Cabot Inc. Acquires 154,851 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. Stock (ISIN: NL0012169213) Drops 16.85% in March Amid Diagnostics Sector Headwinds - AD HOC NEWS
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Pressure Amid Life Sciences Slowdown - AD HOC NEWS
Wellington Management Group LLP Lowers Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Position Raised by Perbak Capital Partners LLP - MarketBeat
Dnca Finance Acquires 39,063 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen NV (QGEN) - MSN
BlackRock Discloses 10.29% Capital Interest and 11.43% Voting Stake in Qiagen - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen (NYSE:QGEN) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft - MarketBeat
Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus
Deutsche Bank Upgrades Qiagen NV(QGEN.US) to Buy Rating - 富途牛牛
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen stock rating to buy on valuation By Investing.com - Investing.com India
Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com
QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider
Qiagen Q2 2025 Earnings Preview - MSN
Capital International Investors Boosts Holdings in Qiagen N.V. $QGEN - MarketBeat
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance
Qiagen discloses Bank of America’s 3.05% stake following AFM notification - TipRanks
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Capital Group Private Client Services Inc. Reduces Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen gains after guidance raise - MSN
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System - BioSpace
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - pharmiweb.com
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat
Qiagen at Leerink Global Healthcare Conference: Strategic Growth and Challenges - Investing.com India
CEO Change: Is Qiagen NV exposed to political risk2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? - Yahoo Finance
Victory Capital Management Inc. Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Did Qiagen’s Strategic Review Signal A Sale, Or Just A SHIFT Toward Capital Returns? - Smartkarma
Segall Bryant & Hamill LLC Lowers Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - The Globe and Mail
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
QIAGEN Updates Total Voting Rights to 206.8 Million - TipRanks
BlackRock Discloses 11.56% Voting Stake in QIAGEN - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
Qiagen Discloses Supervisory Board Member’s Restricted Stock Unit Settlement - The Globe and Mail
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
2.50%
자본화:
|
볼륨(24시간):